Watson To Pay $1.7M To Exit Idaho AG's Drug Pricing Suit

Law360, New York (July 16, 2012, 5:38 PM EDT) -- Watson Pharmaceuticals Inc. on Monday agreed to pay $1.7 million to resolve Idaho's claims that the drug giant charged the state's Medicaid program artificially inflated prices, bringing Idaho's recovery from drug manufacturers targeted in average wholesale price litigation to $22 million.

Watson and subsidiary Watson Pharma Inc. are among the dozens of drugmakers targeted over inflated drug prices in lawsuits brought by state attorneys general across the country. The attorneys general say their states' Medicaid programs used drugmakers' allegedly inflated prices to calculate how much to...
To view the full article, register now.